ASP3652 + Placebo
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Pharmacokinetics
Conditions
Pharmacokinetics, Pharmacodynamics, Healthy Subjects, Safety
Trial Timeline
Aug 1, 2012 → Dec 1, 2012
NCT ID
NCT01815684About ASP3652 + Placebo
ASP3652 + Placebo is a phase 1 stage product being developed by Astellas Pharma for Pharmacokinetics. The current trial status is completed. This product is registered under clinical trial identifier NCT01815684. Target conditions include Pharmacokinetics, Pharmacodynamics, Healthy Subjects.
What happened to similar drugs?
5 of 5 similar drugs in Pharmacokinetics were approved
Approved (5) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (4)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01815684 | Phase 1 | Completed |
| NCT01613586 | Phase 2 | Completed |
| NCT01391338 | Phase 2 | Completed |
| NCT02243657 | Phase 1 | Completed |
Competing Products
20 competing products in Pharmacokinetics